Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study

Emanuel Zitt; Marianne Rix; Pablo Ureña Torres; Denis Fouque; Stefan H Jacobson; Frank Pétavy; Bastian Dehmel; Miroslav Ryba

doi:10.1093/ndt/gfq641

Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study

Emanuel Zitt, Marianne Rix, Pablo Ureña Torres, Denis Fouque, Stefan H Jacobson, Frank Pétavy, Bastian Dehmel, Miroslav Ryba

23 Citationer (Scopus)

Abstract

Progressive secondary hyperparathyroidism (sHPT) is characterized by parathyroid gland hyperplasia which may ultimately require parathyroidectomy (PTX). Although PTX is generally a successful treatment for those patients subjected to surgery, a significant proportion develops recurrent sHPT following PTX. ECHO was a pan-European observational study which evaluated the achievement of KDOQI(TM) treatment targets with cinacalcet use in patients on dialysis. Previously published results showed that cinacalcet plus flexible vitamin D therapy lowered serum PTH, phosphorus and calcium in the clinical practice with similar efficacy as seen in phase III trials.

Originalsprog	Engelsk
Tidsskrift	Nephrology, Dialysis, Transplantation
Vol/bind	26
Udgave nummer	6
Sider (fra-til)	1956-61
Antal sider	6
ISSN	0931-0509
DOI	https://doi.org/10.1093/ndt/gfq641
Status	Udgivet - 1 jun. 2011

Adgang til dokumentet

10.1093/ndt/gfq641

Citationsformater

Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study. / Zitt, Emanuel; Rix, Marianne; Ureña Torres, Pablo et al.
I: Nephrology, Dialysis, Transplantation, Bind 26, Nr. 6, 01.06.2011, s. 1956-61.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{61c431e82030445c8019058d2ce63f29,

title = "Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study",

abstract = "Progressive secondary hyperparathyroidism (sHPT) is characterized by parathyroid gland hyperplasia which may ultimately require parathyroidectomy (PTX). Although PTX is generally a successful treatment for those patients subjected to surgery, a significant proportion develops recurrent sHPT following PTX. ECHO was a pan-European observational study which evaluated the achievement of KDOQI(TM) treatment targets with cinacalcet use in patients on dialysis. Previously published results showed that cinacalcet plus flexible vitamin D therapy lowered serum PTH, phosphorus and calcium in the clinical practice with similar efficacy as seen in phase III trials.",

author = "Emanuel Zitt and Marianne Rix and {Ure{\~n}a Torres}, Pablo and Denis Fouque and Jacobson, {Stefan H} and Frank P{\'e}tavy and Bastian Dehmel and Miroslav Ryba",

year = "2011",

month = jun,

day = "1",

doi = "10.1093/ndt/gfq641",

language = "English",

volume = "26",

pages = "1956--61",

journal = "Nephrology, Dialysis, Transplantation",

issn = "0931-0509",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study

AU - Zitt, Emanuel

AU - Rix, Marianne

AU - Ureña Torres, Pablo

AU - Fouque, Denis

AU - Jacobson, Stefan H

AU - Pétavy, Frank

AU - Dehmel, Bastian

AU - Ryba, Miroslav

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Progressive secondary hyperparathyroidism (sHPT) is characterized by parathyroid gland hyperplasia which may ultimately require parathyroidectomy (PTX). Although PTX is generally a successful treatment for those patients subjected to surgery, a significant proportion develops recurrent sHPT following PTX. ECHO was a pan-European observational study which evaluated the achievement of KDOQI(TM) treatment targets with cinacalcet use in patients on dialysis. Previously published results showed that cinacalcet plus flexible vitamin D therapy lowered serum PTH, phosphorus and calcium in the clinical practice with similar efficacy as seen in phase III trials.

AB - Progressive secondary hyperparathyroidism (sHPT) is characterized by parathyroid gland hyperplasia which may ultimately require parathyroidectomy (PTX). Although PTX is generally a successful treatment for those patients subjected to surgery, a significant proportion develops recurrent sHPT following PTX. ECHO was a pan-European observational study which evaluated the achievement of KDOQI(TM) treatment targets with cinacalcet use in patients on dialysis. Previously published results showed that cinacalcet plus flexible vitamin D therapy lowered serum PTH, phosphorus and calcium in the clinical practice with similar efficacy as seen in phase III trials.

U2 - 10.1093/ndt/gfq641

DO - 10.1093/ndt/gfq641

M3 - Journal article

C2 - 20947534

SN - 0931-0509

VL - 26

SP - 1956

EP - 1961

JO - Nephrology, Dialysis, Transplantation

JF - Nephrology, Dialysis, Transplantation

IS - 6

ER -

Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater